approval · primary record
ERENUMAB-AOOE
FDA · BLA · 2025-06-19
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-06-19 |
| Brand | AIMOVIG |
| Sponsor | AMGEN INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:26.968Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ERENUMAB-AOOE:2025-06-19
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Erenumab-Aooe · compound